FDA approves Eli Lilly drug for thyroid, lung cancers driven by a…

Selpercatinib is the first drug from Loxo's pipeline that Lilly has brought to market.Prior to the acquisition, Loxo won approval of Vitrakvi, which targets a different genetic mutation and is...